Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 4
1987 7
1988 11
1989 17
1990 44
1991 67
1992 71
1993 100
1994 105
1995 131
1996 157
1997 134
1998 152
1999 154
2000 175
2001 237
2002 237
2003 236
2004 255
2005 304
2006 268
2007 226
2008 261
2009 190
2010 208
2011 194
2012 180
2013 178
2014 178
2015 151
2016 174
2017 134
2018 123
2019 106
2020 120
2021 104
2022 87
2023 98
2024 94
2025 92
2026 76

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,395 results

Results by year

Filters applied: . Clear all
Page 1
Pravastatin sodium.
Al-Badr AA, Mostafa GA. Al-Badr AA, et al. Profiles Drug Subst Excip Relat Methodol. 2014;39:433-513. doi: 10.1016/B978-0-12-800173-8.00008-8. Profiles Drug Subst Excip Relat Methodol. 2014. PMID: 24794911 Review.
Pravastatin sodium is an [HMG-CoA] reductase inhibitor and is a lipid-regulating drug. This monograph includes the description of the drug: nomenclature, formulae, elemental composition, solubility, appearance, and partition coefficient. ...The chapter also contains the ph …
Pravastatin sodium is an [HMG-CoA] reductase inhibitor and is a lipid-regulating drug. This monograph includes the description of the …
Pravastatin for lowering lipids.
Adams SP, Alaeiilkhchi N, Tasnim S, Wright JM. Adams SP, et al. Cochrane Database Syst Rev. 2023 Sep 18;9(9):CD013673. doi: 10.1002/14651858.CD013673.pub2. Cochrane Database Syst Rev. 2023. PMID: 37721222 Free PMC article.
BACKGROUND: A detailed summary and meta-analysis of the dose-related effect of pravastatin on lipids is not available. OBJECTIVES: Primary objective To assess the pharmacology of pravastatin by characterizing the dose-related effect and variability of the effect of …
BACKGROUND: A detailed summary and meta-analysis of the dose-related effect of pravastatin on lipids is not available. OBJECTIVES: Pr …
Pravastatin-induced colitis.
Mukhopadhya A, Gilmour H, Plevris J. Mukhopadhya A, et al. Eur J Gastroenterol Hepatol. 2008 Aug;20(8):810-2. doi: 10.1097/MEG.0b013e3282f45740. Eur J Gastroenterol Hepatol. 2008. PMID: 18617789
We report an unusual case of pravastatin-induced colitis in an 80-year old lady. Onset of symptoms was noted within 48 h of starting the medication. ...Drug interaction of pravastatin with amitryptiline could have resulted in this uncommon complication....
We report an unusual case of pravastatin-induced colitis in an 80-year old lady. Onset of symptoms was noted within 48 h of starting …
Expanded table: statins.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Sep 23;61(1581):e152. Med Lett Drugs Ther. 2019. PMID: 31599870 Review. No abstract available.
INOVASIA Study: A Multicenter Randomized Clinical Trial of Pravastatin to Prevent Preeclampsia in High-Risk Patients.
Akbar MIA, Azis MA, Riu DS, Wawengkang E, Ernawati E, Bachnas MA, Sulistyowati S, Dachlan EG, Mose JC, Dekker G. Akbar MIA, et al. Am J Perinatol. 2024 Jul;41(9):1203-1211. doi: 10.1055/a-1798-1925. Epub 2022 Mar 15. Am J Perinatol. 2024. PMID: 35292944 Clinical Trial.
This is an open-label multicenter RCT to evaluate pravastatin effect to prevent preeclampsia.. . Pravastatin significantly reduces the risk of preterm preeclampsia (PE) and preterm birth in high risk PE women.. . Pravastatin had a beneficial effect on perinat …
This is an open-label multicenter RCT to evaluate pravastatin effect to prevent preeclampsia.. . Pravastatin significantly red …
[Pravastatin--misinformation].
Heebøll-Nielsen NC. Heebøll-Nielsen NC. Ugeskr Laeger. 1998 May 4;160(19):2894-5. Ugeskr Laeger. 1998. PMID: 9599572 Danish. No abstract available.
[Research and development of pravastatin].
Kishida Y, Naito A, Iwado S, Terahara A, Tsujita Y. Kishida Y, et al. Yakugaku Zasshi. 1991 Sep;111(9):469-87. doi: 10.1248/yakushi1947.111.9_469. Yakugaku Zasshi. 1991. PMID: 1762049 Review. Japanese.
Since pravastatin has a hydroxyl group at 6 beta position in the skeleton of decaline of ML-236B, the microbial hydroxylation was adopted for the production of pravastatin. ...For the sake of industrial production of pravastatin, many devices and improvements …
Since pravastatin has a hydroxyl group at 6 beta position in the skeleton of decaline of ML-236B, the microbial hydroxylation was ado …
Simvastatin-associated memory loss.
Orsi A, Sherman O, Woldeselassie Z. Orsi A, et al. Pharmacotherapy. 2001 Jun;21(6):767-9. doi: 10.1592/phco.21.7.767.34577. Pharmacotherapy. 2001. PMID: 11401190
A 51-year-old man experienced delayed-onset, progressive memory loss while receiving simvastatin for hypercholesterolemia. His therapy was switched to pravastatin, and memory loss resolved gradually over the next month, with no recurrence of the adverse effect....
A 51-year-old man experienced delayed-onset, progressive memory loss while receiving simvastatin for hypercholesterolemia. His therapy was s …
Allergy to pravastatin.
de Boer EM, Bruynzeel DP. de Boer EM, et al. Contact Dermatitis. 1994 Apr;30(4):238. doi: 10.1111/j.1600-0536.1994.tb00651.x. Contact Dermatitis. 1994. PMID: 8033551 No abstract available.
Optimised transdermal delivery of pravastatin.
Burger C, Gerber M, du Preez JL, du Plessis J. Burger C, et al. Int J Pharm. 2015 Dec 30;496(2):518-25. doi: 10.1016/j.ijpharm.2015.10.034. Epub 2015 Oct 23. Int J Pharm. 2015. PMID: 26505148
The aim of the study was to formulate six different semi-solid formulations (three creams and three emulgels) with 2% pravastatin as the API in order to investigate the "Delivery Gap Principle", by determining which formulation would deliver pravastatin best to the …
The aim of the study was to formulate six different semi-solid formulations (three creams and three emulgels) with 2% pravastatin as …
5,395 results